Skip to main content

Table 1 The baseline characteristics of the study participants

From: Erratum to: A randomized double-blind multi-center trial of hydrogen water for Parkinson’s disease: protocol and baseline characteristics

 

Mean

Std. Deviation

Age

64.2

9.2

Disease duration

6.8

4.5

Sex (male/female) n

90

88

Wearing off (+/−) n

58

120

Dyskinesia (+/−) n

42

136

Levodopa mg

344.1

202.8

Levodopa (+/−) n

154

24

Dopamine agonist levodopa equivalent dose (mg) [12]

166.3

121.1

Total levodopa equivalent dose (mg) [12]a

592.0

317.6

Unified Parkinson’s Disease Rating Scale

Part I

0.7

1.2

Part II

5.6

3.9

Part III

15.7

8.4

Part IV

1.7

2.2

Total

23.7

11.8

Modified Hoehn and Yahr stage

2.1

0.6

Parkinson’s disease Questionnaire-39

Mobility

10.4

9.1

Activities of daily living

5.2

5.1

Emotional well-being

6.0

4.4

Stigma

3.2

2.8

Social support

1.4

1.9

Cognitions

4.0

3.0

Communication

1.7

2.2

Body discomfort

2.5

2.6

Total

34.4

24.2

  1. anot including istradefylline and zonisamide